A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

Phase 2 Completed 100 enrolled GlaxoSmithKline Shionogi · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the drop in viral load over 10 days of treatment with S-1360 versus placebo in HIV-infected patients who have not previously taken anti-HIV medications.

Timeline

Start: 2002-06
Primary completion: 2003-01
Completion: 2003-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	S-1360	Small molecule	—	Oral

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

Summary

Timeline

Drugs

Indications